The COPII pathway and hematologic disease

Blood. 2012 Jul 5;120(1):31-8. doi: 10.1182/blood-2012-01-292086. Epub 2012 May 14.

Abstract

Multiple diseases, hematologic and nonhematologic, result from defects in the early secretory pathway. Congenital dyserythropoietic anemia type II (CDAII) and combined deficiency of coagulation factors V and VIII (F5F8D) are the 2 known hematologic diseases that result from defects in the endoplasmic reticulum (ER)-to-Golgi transport system. CDAII is caused by mutations in the SEC23B gene, which encodes a core component of the coat protein complex II (COPII). F5F8D results from mutations in either LMAN1 (lectin mannose-binding protein 1) or MCFD2 (multiple coagulation factor deficiency protein 2), which encode the ER cargo receptor complex LMAN1-MCFD2. These diseases and their molecular pathogenesis are the focus of this review.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Anemia, Dyserythropoietic, Congenital* / genetics
  • Anemia, Dyserythropoietic, Congenital* / metabolism
  • Anemia, Dyserythropoietic, Congenital* / pathology
  • COP-Coated Vesicles / metabolism
  • COP-Coated Vesicles / pathology*
  • Factor V Deficiency* / genetics
  • Factor V Deficiency* / metabolism
  • Factor V Deficiency* / pathology
  • Hemophilia A* / genetics
  • Hemophilia A* / metabolism
  • Hemophilia A* / pathology
  • Humans
  • Mannose-Binding Lectins / genetics
  • Mannose-Binding Lectins / metabolism
  • Membrane Proteins / genetics
  • Membrane Proteins / metabolism
  • Vesicular Transport Proteins / genetics
  • Vesicular Transport Proteins / metabolism

Substances

  • LMAN1 protein, human
  • MCFD2 protein, human
  • Mannose-Binding Lectins
  • Membrane Proteins
  • SEC23B protein, human
  • Vesicular Transport Proteins